Answers are grounded in this paper and cite their sources.
An interesting paper published in this issue of IJA by Aschim et al. (2004) provided further epidemiological evidence for the testicular dysgenesis syndrome (TDS) hypothesis, which suggests that hypospadias, testicular cancer, abnormal spermatogenesis and undescended testis may be different manifestations of the same syndrome, linked together by common risk factors. Research in clinical syndromes often starts with interesting clinical observations, which stimulate subsequent systematic investigations, including epidemiological studies. However, in the case of TDS it was the other way around. The initial hypothesis was based upon a mosaic of several pieces of epidemiological and biological information (Skakkebæk et al., 2001). After we became aware of the symptoms of TDS it was then easy to identify a series of 20 TDS patients in our clinic (Skakkebæk et al., 2003). We now regularly diagnose such patients among men referred to our andrology clinic for infertility or testicular cancer, as many also have other manifestations of TDS. Clinical management of congenital abnormalities of the reproductive organs, spermatogenic disorders and testicular cancer has been split between paediatric endocrinologists, andrologists, gynaecologists and urologists. This clinical structure has most likely delayed progress in research on TDS. Research reports on testicular germ cell cancer illustrate this: before 1980–1990 the leading journals for reproductive medicine and endocrinology very rarely published papers on testicular cancer, which was mainly a topic for urological or pathological journals. Germ cell cancer was usually not classified as a disorder with interesting endocrine aspects except from choriocarcinomas. And the link between pre-existing subfertility and poor semen quality in men with testicular cancer was not firmly established until few years ago (Møller & Skakkebæk, 1999; Richiardi et al., 2004). On the contrary, it has been textbook knowledge for decades that men with a history of undescended testis run an increased risk of impaired spermatogenesis and testicular cancer. Important milestones in the process towards the TDS hypothesis have been (i) the demonstration that testicular cancer in adults originates from carcinoma in situ cells, which are gonocyte-like transformed germ cells, which failed to differentiate into spermatogonia during the foetal period (Skakkebæk et al., 1987), and (ii) the more recent evidence of the stem cell properties of the CIS cells, which express a number of genes in common with gonocytes and embryonic stem cells, for example c-Kit and Oct-4 (Looijenga et al., 2003; Rajpert-De Meyts et al., 2003). Furthermore, there is now strong epidemiological evidence that prenatal exposures are important for the development of germ cell cancer in an adult. Some studies have shown that the risk is related to the year of birth (Møller et al., 1993b), and an association between small for gestational weight and germ cell cancer has also be established. Low birth weight is also a risk factor for undescended testis and hypospadias. Aschim et al. (2004) not only confirmed the association between low birth weight and hypospadias, but interestingly also found evidence for other prenatal factors for hypospadias, including retained placenta and low parity, the latter is also a risk factor for other parts of TDS including testicular cancer and cryptorchidism (Sharpe, 2003). Unfortunately, the incidence of the various symptoms of TDS is increasing in the Western populations. The most convincing change is the increase in testicular cancer in practically all countries with cancer registration (Møller, 1993b). However, there are very striking differences in testicular cancer incidence. It seems that genetic factors are important, as African Americans have significantly lower incidence than Caucasians, living in the same areas of USA. Furthermore, families with two or more cases of testicular cancer have been reported, indicating that testicular cancer susceptibility genes exist (Rapley et al., 2003). But not all differences can be explained by genetics: striking differences in testicular cancer incidence exist between Nordic countries with similar economic and social structures. Denmark has a world record with the highest incidence, while Finland, on the other hand, is among the countries with the lowest incidence of testicular cancer (several times lower than Denmark). An epidemiological study addressing the question about aetiology strongly suggested that environmental factors were to blame for this difference (Hemminki & Li, 2002). But there are no clues regarding the aetiological factors behind this interesting phenomenon, which is under scientific scrutiny in several ongoing studies. However, it was recently shown that also semen quality of the general population was lower, and the incidence of undescended testis was higher in Denmark compared with Finland, in line with the assumption that these disorders are epidemiological linked with each other and with testicular cancer (Jørgensen et al., 2001; Boisen et al., 2004). Although the genetics of undescended testis, testicular cancer, hypospadias and oligozoospermia in most cases is poorly understood, important advances in our understanding of the role of genes located on the Y chromosome for human spermatogenesis have been achieved (Krausz et al., 2003). However, in quantitative terms the infertile men with spermatogenic disorders who have Y chromosome deletions constitute a small part of men in infertility clinics. Furthermore, a recent study failed to detect an association between Y chromosome deletion and testicular cancer. In cases with some rare chromosome disorders with genital abnormalities, including individuals with so-called mixed gonadal dysgenesis and 45,X/46,XY karyotype or phenotypic 46,XY females with pure gonadal dysgenesis there is an increased risk of developing germ cell cancer. In such individuals the abnormal genetic constitution may be associated with dysgenetic changes in the gonads, including microlithiasis, undifferentiated Sertoli cells/granulosa-like cells and persistence of undifferentiated gonocytes in the maldeveloped gonad, sometimes in the form of gonadoblastoma (Scully, 1970). However, recent research has shown that similar dysgenetic changes can also occasionally be seen in testicular biopsies of men with a normal 46,XY karyotype and maldescended testis, and/or infertility; and in the contralateral testis of men with testicular cancer (Høi-Hansen et al., 2003; Skakkebæk et al., 2003). The quantitative role of TDS for male infertility remains to be elucidated. We should not forget that male infertility is just a symptom, and several genetic and environmental factors can cause hypospermatogenesis. Furthermore, the cause of male infertility is in most cases unknown. However, an oligozoospermic male with testicular biopsy showing microlithiasis and/or dysgenetic seminiferous tubules with undifferentiated Sertoli cells and/or carcinoma in situ testis should probably be classified as a case of TDS. We are still in the dark with regard to the pathogenesis of testicular dysgenesis. Few are clearly caused by genetic defects. But the increasing incidence of TDS suggests that environmental exposures are important. Several ongoing epidemiological studies are testing an endocrine disrupter hypothesis that foetal environmental exposures from agents with estrogenic or antiandrogenic effects may result in TDS (Toppari et al., 1996). Recently, also experimental animal models have been developed (Fisher et al., 2003; Higuchi et al., 2003; Barlow et al., 2004). They may prove to be of important value for our understanding of the pathogenesis of TDS. In spite of our ignorance about aetiology, andrologists and other clinicians treating male infertility should bear in mind that some infertile men may benefit from clinical work-up for TDS symptoms. Besides poor semen quality, some infertile men are at risk of other manifestations of TDS, including a silent neoplasia in the testis. Therefore, ultrasound of the testis to detect microlithiasis or occult cancer (Holm et al., 2003) should now be obligatory in management of an infertile man with oligozoospermia, small testes and/or a history of undescended testis.
No takes yet. Share an insight, caveat, or question.
Niels E. Skakkebæk (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: